Solusi Bangun Indonesia Tbk PT
IDX:SMCB
Solusi Bangun Indonesia Tbk PT
IDX:SMCB
Price:
735
IDR
Market Closed
Market Cap:
6.6T
IDR
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
SMCB Alert
Solusi Bangun Indonesia Tbk PT
735
0 (0%)
| 52 Week Range |
610
1 400
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Solusi Bangun Indonesia Tbk PT
Balance Sheet
Balance Sheet Decomposition
Solusi Bangun Indonesia Tbk PT
Solusi Bangun Indonesia Tbk PT
| Current Assets | 4.9T |
| Cash & Short-Term Investments | 271.9B |
| Receivables | 2.6T |
| Other Current Assets | 2T |
| Non-Current Assets | 16.4T |
| PP&E | 15.7T |
| Intangibles | 332.6B |
| Other Non-Current Assets | 350.7B |
| Current Liabilities | 4.6T |
| Accounts Payable | 3.9T |
| Accrued Liabilities | 474.4B |
| Other Current Liabilities | 274.8B |
| Non-Current Liabilities | 4T |
| Long-Term Debt | 2T |
| Other Non-Current Liabilities | 2T |
Balance Sheet
Solusi Bangun Indonesia Tbk PT
Solusi Bangun Indonesia Tbk PT
Currency: IDR
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
201 461
|
358 678
|
314 192
|
542 330
|
331 347
|
386 751
|
526 813
|
290 567
|
294 344
|
339 455
|
|
| Cash |
201 461
|
358 678
|
314 192
|
542 330
|
331 347
|
386 751
|
526 813
|
0
|
294 344
|
339 455
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
290 567
|
0
|
0
|
|
| Short-Term Investments |
13 109
|
279 657
|
9 637
|
5 488
|
5 259
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
1 178 161
|
1 258 919
|
1 257 315
|
1 380 903
|
1 095 238
|
1 527 499
|
2 415 811
|
3 470 296
|
2 881 470
|
4 006 690
|
|
| Accounts Receivables |
1 037 399
|
1 113 648
|
1 040 587
|
1 208 291
|
1 021 383
|
1 360 891
|
2 337 542
|
3 280 042
|
2 726 449
|
3 787 073
|
|
| Other Receivables |
140 762
|
145 271
|
216 728
|
172 612
|
73 855
|
166 608
|
78 269
|
190 254
|
155 021
|
219 617
|
|
| Inventory |
628 857
|
553 364
|
556 291
|
880 760
|
962 614
|
1 102 680
|
1 048 354
|
1 019 014
|
1 262 429
|
1 171 348
|
|
| Other Current Assets |
244 601
|
180 466
|
302 529
|
110 837
|
203 214
|
189 908
|
225 237
|
458 392
|
620 917
|
573 565
|
|
| Total Current Assets |
2 266 189
|
2 631 084
|
2 439 964
|
2 920 318
|
2 597 672
|
3 206 838
|
4 216 215
|
5 238 269
|
5 059 160
|
6 091 058
|
|
| PP&E Net |
14 498 240
|
14 427 080
|
16 608 121
|
15 999 771
|
15 468 710
|
15 465 852
|
15 725 265
|
15 278 538
|
15 420 351
|
15 535 196
|
|
| PP&E Gross |
14 498 240
|
14 427 080
|
16 608 121
|
15 999 771
|
15 468 710
|
15 465 852
|
15 725 265
|
15 278 538
|
15 420 351
|
15 535 196
|
|
| Accumulated Depreciation |
7 306 727
|
7 776 062
|
9 465 519
|
10 431 742
|
11 365 141
|
11 840 303
|
12 354 427
|
13 387 333
|
14 113 591
|
14 861 897
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
21 583
|
15 089
|
15 776
|
1 200
|
873
|
|
| Goodwill |
120 242
|
23 366
|
401 809
|
401 808
|
331 808
|
331 808
|
331 808
|
331 808
|
331 808
|
331 808
|
|
| Note Receivable |
42 618
|
76 566
|
28 066
|
108 738
|
96 780
|
443 132
|
355 626
|
513 546
|
442 094
|
117 347
|
|
| Other Long-Term Assets |
131 380
|
212 779
|
285 173
|
195 768
|
172 217
|
98 285
|
94 122
|
113 086
|
123 897
|
130 457
|
|
| Other Assets |
120 242
|
23 366
|
401 809
|
401 808
|
331 808
|
331 808
|
331 808
|
331 808
|
331 808
|
331 808
|
|
| Total Assets |
17 199 304
N/A
|
17 370 875
+1%
|
19 763 133
+14%
|
19 626 403
-1%
|
18 667 187
-5%
|
19 567 498
+5%
|
20 738 125
+6%
|
21 491 023
+4%
|
21 378 510
-1%
|
22 206 739
+4%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
1 066 695
|
1 082 122
|
1 121 004
|
1 360 393
|
1 248 653
|
1 482 448
|
2 014 981
|
3 101 191
|
4 101 180
|
4 282 319
|
|
| Accrued Liabilities |
685 080
|
634 952
|
805 461
|
892 893
|
839 588
|
564 770
|
526 455
|
503 864
|
500 120
|
482 317
|
|
| Short-Term Debt |
495 990
|
223 362
|
1 161 890
|
847 320
|
1 307 083
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
874 041
|
1 733 124
|
1 879 765
|
1 720 776
|
5 794 604
|
116 110
|
1 435 748
|
213 565
|
135 462
|
522 633
|
|
| Other Current Liabilities |
685 739
|
333 191
|
343 238
|
563 421
|
549 847
|
800 178
|
164 081
|
80 786
|
112 398
|
231 614
|
|
| Total Current Liabilities |
3 807 545
|
4 006 751
|
5 311 358
|
5 384 803
|
9 739 775
|
2 963 506
|
4 141 265
|
3 899 406
|
4 849 160
|
5 518 883
|
|
| Long-Term Debt |
4 052 179
|
4 205 164
|
5 208 134
|
5 767 152
|
1 151 801
|
8 546 350
|
7 497 378
|
4 494 309
|
2 774 627
|
2 393 471
|
|
| Deferred Income Tax |
284 132
|
239 523
|
660 507
|
656 803
|
708 940
|
535 711
|
674 445
|
1 011 863
|
1 112 133
|
1 203 377
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
473 479
|
469 580
|
522 539
|
620 694
|
650 321
|
539 319
|
858 858
|
886 373
|
782 552
|
586 394
|
|
| Total Liabilities |
8 621 347
N/A
|
8 921 018
+3%
|
11 702 538
+31%
|
12 429 452
+6%
|
12 250 837
-1%
|
12 584 886
+3%
|
13 171 946
+5%
|
10 291 951
-22%
|
9 518 472
-8%
|
9 702 125
+2%
|
|
| Equity | |||||||||||
| Common Stock |
3 831 450
|
3 831 450
|
3 831 450
|
3 831 450
|
3 831 450
|
3 831 450
|
3 831 450
|
4 509 691
|
4 509 691
|
4 509 691
|
|
| Retained Earnings |
2 369 251
|
2 228 859
|
1 829 331
|
1 071 286
|
243 301
|
742 353
|
1 358 279
|
1 936 210
|
2 559 206
|
3 202 068
|
|
| Additional Paid In Capital |
2 472 381
|
2 587 309
|
2 587 309
|
2 587 309
|
2 587 309
|
2 587 309
|
2 587 309
|
5 014 275
|
5 014 275
|
5 014 275
|
|
| Other Equity |
95 125
|
197 761
|
187 495
|
293 094
|
245 710
|
178 500
|
210 859
|
261 104
|
223 134
|
221 420
|
|
| Total Equity |
8 577 957
N/A
|
8 449 857
-1%
|
8 060 595
-5%
|
7 196 951
-11%
|
6 416 350
-11%
|
6 982 612
+9%
|
7 566 179
+8%
|
11 199 072
+48%
|
11 860 038
+6%
|
12 504 614
+5%
|
|
| Total Liabilities & Equity |
17 199 304
N/A
|
17 370 875
+1%
|
19 763 133
+14%
|
19 626 403
-1%
|
18 667 187
-5%
|
19 567 498
+5%
|
20 738 125
+6%
|
21 491 023
+4%
|
21 378 510
-1%
|
22 206 739
+4%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
7 663
|
7 663
|
7 663
|
7 663
|
7 663
|
7 663
|
7 663
|
9 019
|
9 019
|
9 019
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
